🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To Estimate Bioavailability Of 40 Mg Doses Of Pf-00345439 Formulation K Und...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2014-07
Trial ID
NCT02165930
Treatments Being Tested
The main purpose of this study is to simulate if oxycodone and naltrexone c...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2013-07
Trial ID
NCT01825447
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled, parall...
Status
Completed
Location
Premier Research
Start Date
2015-06
Trial ID
NCT02401750
Treatments Being Tested
To estimate the pharmacokinetics and relative bioavailability of oxycodone ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-04
Trial ID
NCT01552850
To estimate the effect of food on the pharmacokinetics and relative bioavai...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2014-04
Trial ID
NCT02117583
This is an open-label (both the physician and healthy volunteer know which ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-03
Trial ID
NCT01552863
To evaluate the dose proportionality of 5 mg, 20 mg and 40 mg of PF 0034543...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2014-04
Trial ID
NCT02089295
To determine whether the bioavailability of the controlled-release test for...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-09
Trial ID
NCT01677065
Treatments Being Tested
This is a single-center study incorporating 2 parts: A Multiple Ascending D...
Status
Completed
Location
PRA Health Sciences-Early Development Services
Start Date
2021-09-08
Trial ID
NCT05043766
Treatments Being Tested
The study is designed to test whether or not the rate and extent of absorpt...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-09
Trial ID
NCT01677039